Friday, October 30, 2009

Latest News


Sunday, February 8, 2009

LI OCEANS bringing light to Ovarian Cancer

A Beacon of Hope for those affected by Ovarian Cancer...

LONG ISLAND OVARIAN CANCER EDUCATION ADVOCACY NETWORK SUPPORT.

A Long Island grassroots 501 C Non Profit Organization made up of survivors from the newly diagnosed to the long term survivor. Helping women from Montauk to Manhatten.

Tuesday, April 22, 2008

Ovarian Cancer Grassroots Action Network-OCNA

Bisphenol A Fact Sheet-ny Toxic Nation

BPA- inceases the risk for breast, ovarian and prostate cancer

The Canadian Federal government has announced its intention to ban the import and sale of plastic baby bottles containing bisphenol A. Several studies have found that the chemical, also known as BPA, can leach into a bottle's contents, increasing the risk for breast, ovarian and prostate cancer, even at low doses. A ban on BPA would make Canada the first country in the world to take such measures.

An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment

A Hard Plastic Is Raising Hard Questions

Drug Compound Leads To Death Of Ovarian Cancer Cells Resistant To Chemotherapy

Ovarian Cancer Stem Cells Identified, Characterized

Canada Labels BPA Baby Bottles "Toxic"

More stores pull bisphenol A plastics from shelves

Toys 'R' Us to phase out bisphenol A baby bottles

Ovarian Cancer, Silent no more!

http://www.youtube.com/watch?v=Ces9g7E-1wI

Monday, April 21, 2008

Since You Asked - Bisphenol A

Surviving Cancer Doesn’t Lead to Healthier Lifestyle

Friday, April 18, 2008

Bottle Maker to Stop Using Plastic Linked to Health Concerns

Tuesday, March 25, 2008

Birth control pills' protection from ovarian cancer may last decades

4th Annual Indian Island Charity Golf Outing


4th Annual Indian Island Charity Golf Outing


Long Island O.C.E.A.N.S. Ovarian Cancer Education Advocacy and Support


Monday, June 16th 12:00 Check-In 1:00 Shotgun



Sponsorships Opportunities
Dinner Sponsor 
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$1000.00

Beverage Golf Cart Sponsor 
Dinner for 1 person
Promotional Sign on Beverage Cart
$250.00

Lunch Sponsor 
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$500.00

Tee Sign Sponsor 
Promotional sign on golf hole.
$100.00

Practice Range Sponsor
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$500.00

Putting Practice Green Sponsor
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$500.00

Other types of donations accepted:
Gift Certificates, Gift Baskets, Retail Items, Art, Memberships, etc..

Please write exactly what you would like your sign/banner to display:



Amount Enclosed $______________________

Send payment to Indian Island Country Club Att: Russ Moran:
(Make Checks Payable to Long Island Oceans)

Ph. 631-727-0788 Fax. 631-727-0861 http://www.indianislandcatering.com/

Indian Island Country Club

Att: Russ Moran

661 Riverside Drive Riverhead, NY 11901

Sunday, March 16, 2008

8th Annual Stowe Weekend of Hope

Monday, March 10, 2008

Global Montage of Special Ovarian Cancer Women


The infamous Sandi Pniauskas behind the Camera...Check out Sandi's amazing Global Montage made up of truly Special Ovarian Cancer Women.

Ovarian cancer treatment promise

Phenoxodiol Trials Highlighted at Ovarian Cancer Action International Conference

Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer

Advanced-stage Ovarian Cancer Patients With BRCA Live Longer, May Respond Better To Treatment, Study Shows

Advanced-stage Ovarian Cancer Patients With BRCA Live Longer, May Respond Better To Treatment, Study Shows

The second annual Johns Hopkins NanoBio Symposium will be held May 1-2, 2008 at the Johns Hopkins School of Medicine

Recurrent Low-grade Carcinoma Of The Ovary Less Responsive To Chemo Than More Common Ovarian Cancers

Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1.

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth

A New ELISA for Use in a 3-ELISA System to Assess Concentrations of VEGF Splice Variants and VEGF110 in Ovarian Cancer Tumors

Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein

Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer

Call on the House of Representatives to Fund Johanna's Law on Wednesday Call-in-Day Wednesday, March 12th for Johanna's Law Funding

Call on the House of Representatives to Fund Johanna's Law on Wednesday
Call-in-Day Wednesday, March 11 for Johanna's Law Funding

Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease

Vermillion Reports Success of Ovarian Cancer Biomarker Panel

Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment

Thursday, March 6, 2008

A new Hope Lodge opens in New York

NY-Times Cancer Funding: Does it add up?

March 6, 2008, 12:21 pm

Cancer Funding: Does It Add Up?

Should cancer spending be focused on the most common cancers? Or the most deadly cancers?

That’s the dilemma for the cancer research community as it struggles to divvy up limited funds. After news yesterday that actor Patrick Swayze had been diagnosed with pancreatic cancer, several readers questioned the nation’s cancer funding priorities. I decided to look at the numbers.

The National Cancer Institute spends about $6 billion a year in the war on cancer, allocating some funds for general cancer research and some for studies of specific cancers. But a review of the N.C.I.’s 2006 funding for five of the biggest cancers showed a wide disparity in the amounts of money spent relative to each cancer death and each new case of cancer. The data offer only a partial snapshot of public cancer spending in this country, as other government offices, such as the U.S. Department of Defense, also fund breast and prostate cancer research.

The big loser in the cancer funding race is lung cancer. It is the biggest cancer killer in the country, yet on a per-death basis receives the least N.C.I. funding among major cancers. In 2006, the N.C.I. spent $1,518 for each new case of lung cancer and $1,630 for each lung cancer death, according to data from the institute and the American Cancer Society.

Among the big cancers, breast cancer receives the most funding per new case, $2,596 — and by far the most money relative to each death, $13,452. Notably, prostate cancer, the most common cancer, receives the least funding per new case at just $1,318. But on a per-death basis it ranks second, with $11,298 in N.C.I. funds.

Here’s a look at the N.C.I. cancer funding based on 2006 death rates and incidence rates for some of the most common and deadliest cancers.

Cancer (Deaths)
N.C.I. Funding per Death
Lung (162,460)
$1,630
Colon (55,170)
$4,566
Breast (41,430)
$13,452
Pancreas (32,300 )
$2,297
Prostate (27,350)
$11,298
Cancer (New cases)
N.C.I. Funding per New Case
Prostate (234,460)
$1,318
Lung (174,470)
$1,518
Breast (214,640)
$2,596
Colon (106,680)
$2,361
Pancreas (33,730)
$2,200

NY-Times Ovarian Cancer

Wednesday, March 5, 2008

New Ovarian Cancer Test Now Available in Europe

Make Sure Your Representative Signs the Ovarian-Prostate Dear Colleague Letter

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer

Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats

High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells

Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to

Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer

Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs

In vitro screening assay for detecting aromatase activity using rat ovarian microsomes and estrone ELISA

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth.

Women With Undiagnosed Colorectal Adenocarcinomas Presenting With Ovarian Metastases: Clinicopathologic Features and Comparison With Women Having Know

Plasma androgen concentrations and risk of incident ovarian cancer.

Migration deficit in monocyte-macrophages in human ovarian cancer.

Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to

Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor.

Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer.

Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.

Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.

Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cell

DeltaNp63 expression is associated with poor survival in ovarian cancer

Amplification of 11q13 in ovarian carcinoma.

Vitamin D: Cancer Prevention's Sunny Future?

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

New Ovarian Cancer Treatment?

Woman's Doctor: Caffeine & Cancer

Protein That Fuels Ovarian Cancer Identified and Shut Down By Researchers

Thalomid® Improves Response to Hycamtin® for Recurrent Ovarian Cancer

TAT 2008 6TH INTERNATIONAL SYMPOSIUM ON TARGETED ANTICANCER THERAPIES

Tuesday, March 4, 2008

PBS April 16th, " The Truth About Cancer"


Monday, February 18, 2008

Yale Test Detects Early Stage Ovarian Cancer With 99 Percent Accuracy

Diagnostic Markers for Early Detection of Ovarian Cancer

Friday, February 8, 2008

Charity Event to Break The Silence of Ovarian Cancer

Back In Motion ~ A Night Of Golden Memories"

CHARITY EVENT TO BREAK THE SILENCE OF OVARIAN CANCER

A fun-filled evening of networking, music, fine food, prizes and nostalgia will take place on April 1, 2008 from 6:00 P.M. – 10 P.M. at the Inn at New Hyde Park. The fundraising event is sponsored by Pro-fusion, home of the Long Island Breakfast Club, a career advocacy organization for mature professionals.

Wednesday, December 12, 2007

LIPPzzzz -- Long Island Pajama Party- Girlz Night Out!

Mark your calendars!
LIPPzz ~ Long Island Pajama Party
Girlz Night Out Event
Friday, February 1st, 2008

Huntington Hilton

7:00 PM - Midnight